AMMANNATI PAOLA has a total of 14 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Brazil, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, foods and drinks and machines are THROMBOLYTIC SCIENCE LLC, LACLEDE INC and NUBIOME INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Brazil | 2 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Republic of Korea | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Australia | 1 | |
#7 | Canada | 1 | |
#8 | Russian Federation | 1 | |
#9 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Enzymes | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Ammannati Paola | 12 |
#2 | Giordani Roberto | 11 |
#3 | Roberto Ammannati Paola Giorda | 2 |
#4 | Dzhordani Roberto | 1 |
Publication | Filing date | Title |
---|---|---|
BRPI0418858A | enzymatic treatment of retinitis pigmentosa and pharmaceutical composition relevant to it in the form of a kit | |
KR20070029726A | Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition therefor in form of a kit | |
EP1545590A1 | Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition in form of a kit | |
RU2304446C2 | Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition as a kit applied for such therapy | |
KR20050090120A | Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition in form of a kit |